ArticleFrontiers in cell and developmental biology2025

Cooperative targeting of NF-κB enhances ferroptosis-driven HCC therapy with Alisertib and Donafenib.

Qiong Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.